Non-small cell lung cancer cells with uncommon EGFR exon 19delins variants respond poorly to third-generation EGFR inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Non-small cell lung cancer cells with uncommon EGFR exon 19delins variants respond poorly to third-generation EGFR inhibitors

Published:2024-01 Issue: Volume:39 Page:101834
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Lu Zhiqin,Yi Yali,Wang Linxiao,Luo Yuxi,Luo Daya,Xiong Le,Shu Yun,Luo Hui,Li Jing,Zhu Wufu,Zeng Zhimin,Liu Anwen^ORCID

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangxi Province

Nanchang University

Foundation for Innovative Research Groups of the National Natural Science Foundation of China

Foundation of Jiangxi Educational Commission

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference42 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Uncommon EGFR mutations in advanced non-small cell lung cancer;O'Kane;Lung Cancer,2017

3. Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors;Gazdar;Oncogene,2009

4. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial;Rosell;Lancet Oncol.,2012

5. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;Maemondo;New England J. Med.,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP